The latest studies revealed that METTL3 activates the m6A-BHLHE41-CXCL1/CXCR2 pathway, recruiting myeloid-derived suppressor cells within the immune microenvironment of CRC. This evidence concerns the gene METTL3 and colorectal carcinoma.